Roivant Sciences GAAP EPS of -$0.38 misses by $0.07, revenue of $1.99M misses by $4.15M
Source: SeekingAlpha
2026-02-06 07:07:16 ET
More on Roivant Sciences
- Roivant Sciences: King Of The Vants Prepares To Drop Vantism In Search Of Greater Growth
- Roivant Sciences Ltd. (ROIV) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Roivant Sciences Ltd. (ROIV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Roivant Sciences Q3 2026 Earnings Preview
- LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks
Read the full article on Seeking Alpha
For further details see:
Roivant Sciences GAAP EPS of -$0.38 misses by $0.07, revenue of $1.99M misses by $4.15M
Roivant Sciences Ltd.
NASDAQ: ROIV
ROIV Trading
-0.05% G/L:
$29.965 Last:
1,359,287 Volume:
$29.49 Open:
ROIV Latest News
March 04, 2026 11:42:41 pm
BlackBarn Capital Builds Warby Parker Stake as the Direct-to-Consumer Eyewear Leader Expands Nationwide
March 03, 2026 04:15:00 pm
Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna
March 03, 2026 04:15:00 pm
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
ROIV Stock Data
$19,574,426,097
449,460,314
0.77%
170
N/A
Biotechnology & Life Sciences
Healthcare
GB
London
